These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25569)

  • 1. [Renin and age, determinants of the beta-blocker effect in essential hypertension].
    Bühler FR
    Adv Clin Pharmacol; 1976; 11():42-53. PubMed ID: 25569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ambulant and stationary determination of the renin-sodium index in the classification and treatment of essential hypertension].
    Bühler FR; Patel U; Marbet G
    Schweiz Med Wochenschr; 1974 Dec; 104(49):1802-5. PubMed ID: 4156423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension].
    Stumpe KO; Vetter H; Hessenbroch V; Kolloch R; Düsing R; Krück F
    Verh Dtsch Ges Inn Med; 1975; 81():1038-41. PubMed ID: 7048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-blocking agents in the treatment of hypertension.
    Stumpe KO; Kolloch RE
    Compr Ther; 1977 May; 3(5):55-65. PubMed ID: 16724
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypotensive and renin-stimulating action of captopril at first and during treatment with a beta-blocker].
    Bianchini C; Terzoli L; Leonetti G; Banfi E; Castelli D; Zanchetti A
    Cardiologia; 1982; 27(4):381-5. PubMed ID: 6152734
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 11. "Tailored" application of beta-blockers in hypertension: a continuing dilemma.
    Birkenhäger WH; de Leeuw PW; Wester A; Kho TL; Vandongen R; Falke HE
    Neth J Med; 1977; 20(3):116-22. PubMed ID: 18688
    [No Abstract]   [Full Text] [Related]  

  • 12. [The potential of beta-blockaders in the management of hypertension].
    Bühler FR; Kowski W; Bolli P; Bertel O
    Internist (Berl); 1978 Sep; 19(9):510-9. PubMed ID: 29849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of changes of posture, beta-blocking agents and the cold pressure test on the levels of plasma renin activity (PRA) in essential hypertension with low serum renin].
    Del Guercio R; Gentile S; Saponara A; De Buono AF
    Clin Ter; 1980 Sep; 94(6):627-34. PubMed ID: 6109590
    [No Abstract]   [Full Text] [Related]  

  • 14. Renin profiling for diagnosis and treatment of hypertension.
    Laragh JH; Letcher RL; Pickering TG
    JAMA; 1979 Jan; 241(2):151-6. PubMed ID: 31492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 16. Bucindolol in essential hypertension.
    Reid JL; Curzio J; Vincent J
    Int J Clin Pharmacol Res; 1985; 5(5):293-301. PubMed ID: 2866166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood pressure, renin, angiotension II and catecholamines in the plasma of healthy subjects and patients with essential hypertension before and after beta blockade].
    Schuchard J; Wober W; Dahlheim H; Thurau K; Lydtin H
    Adv Clin Pharmacol; 1976; 11():61-5. PubMed ID: 25570
    [No Abstract]   [Full Text] [Related]  

  • 18. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination therapy of arterial hypertension].
    von Manteuffel GE; Ebel H; Zehner J
    Med Klin; 1980 Apr; 75(8):297-302. PubMed ID: 6104777
    [No Abstract]   [Full Text] [Related]  

  • 20. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.